SEC Form 4 research
| Issuer | AIM ImmunoTech Inc. |
|---|---|
| Tickers | AIM, HEB |
| Reporting owners | 22 |
| Officers and directors | 11 |
| Last public filing | 2026-11-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-18 | 2026-11-18 | Equels Thomas K | P | 20,000 | $0.13 | Not reported |
| 2026-11-17 | 2026-11-16 | Equels Thomas K | P | 38,000 | $0.14 | Not reported |
| 2026-11-13 | 2026-11-11 | Equels Thomas K | P | 35,000 | $0.15 | Not reported |
| 2026-11-12 | 2026-11-10 | Equels Thomas K | P | 39,000 | $0.14 | Not reported |
| 2026-11-10 | 2026-11-09 | Equels Thomas K | P | 31,298 | $0.16 | Not reported |
| 2026-11-09 | 2026-11-06 | Equels Thomas K | P | 12,751 | $0.16 | Not reported |
| 2026-11-06 | 2026-11-06 | Equels Thomas K | P | 20,299 | $0.16 | Not reported |
| 2026-10-26 | 2026-10-23 | Equels Thomas K | P | 31,675 | $0.16 | Not reported |
| 2026-10-23 | 2026-10-22 | Equels Thomas K | P | 31,250 | $0.16 | Not reported |
| 2026-09-18 | 2026-09-17 | Equels Thomas K | P | 24,000 | $0.21 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.